Spire Healthcare Group (LON:SPI – Get Free Report) announced its earnings results on Wednesday. The company reported GBX (0.50) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a negative net margin of 0.12% and a negative return on equity of 0.26%.
Spire Healthcare Group Stock Performance
Shares of LON:SPI remained flat at GBX 247.50 during trading on Friday. The company had a trading volume of 5,485,459 shares, compared to its average volume of 5,428,408. The stock has a market capitalization of £991.48 million, a P/E ratio of 61.88, a PEG ratio of 1.06 and a beta of 0.93. Spire Healthcare Group has a fifty-two week low of GBX 140.80 and a fifty-two week high of GBX 249. The company has a quick ratio of 0.73, a current ratio of 0.58 and a debt-to-equity ratio of 180.14. The firm’s fifty day simple moving average is GBX 239.06 and its 200-day simple moving average is GBX 208.32.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada lowered shares of Spire Healthcare Group to a “sector perform” rating and decreased their price target for the company from GBX 300 to GBX 250 in a report on Monday, September 7th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Spire Healthcare Group has an average rating of “Moderate Buy” and a consensus target price of GBX 247.50.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
See Also
- Five stocks we like better than Spire Healthcare Group
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
